ZOBIA WASIELCZYK: Open Payments
NPI 1659952513 · LAVEEN, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 18 payments from 11 companies in 2025. Trend: 2023 $30 · 2024 $176 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $107 |
| Novo Nordisk Inc | 3 | $61 |
| Eisai Inc. | 1 | $48 |
| Lilly USA, LLC | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: QULIPTA, Leqembi, MOUNJARO, UBRELVY, SHINGRIX, TONMYA, FARXIGA, Cologuard Collection Kit.
Industry payments across AZ — which companies pay providers there.
